The 20 Best Squamous Cell Skin Carcinoma Doctors Near Me in New Hyde Park, NY

Kishwer Nehal is a Dermatologist practicing medicine in New York, New York. Dr. Nehal is rated as an Elite provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Carole Hazan is a Dermatologist practicing medicine in New Hyde Park, New York. Dr. Hazan is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Telangiectasia, Spider Angioma, Keloids, and Squamous Cell Skin Carcinoma.

Jeanne Franck is a Dermatologist practicing medicine in Garden City, New York. Dr. Franck is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Squamous Cell Skin Carcinoma, Extramammary Paget Disease, Basal Cell Skin Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Dr. Bhuvanesh Singh, a board-certified otolaryngologist and physician scientist with a distinction in research, specializes in head and neck surgery and reconstruction with a particular expertise in skin cancers. He joins Northwell after 27 years at Memorial Sloan-Kettering Cancer Center, where he served as the director of Laboratory of Epithelial Cancer Biology and founder and co-director of the Advanced Skin Cancer Management and Prevention Program. A recognized leader in his field, Dr. Singh has served on the AJCC staging and NCCN guideline committees. He has published over 300 peer-reviewed manuscripts, 30 book chapters, and several textbooks, including one of the leading textbooks in head and neck oncology. He has delivered over 500 lectures worldwide. Additionally, as an NIH-funded researcher, he developed a novel antineoplastic compound that is currently being codeveloped with a pharmaceutical company for human use.Dr. Singh has performed over 10,000 surgical procedures, the experience from which has allowed him to develop innovative surgical approaches that have significantly enhanced outcomes for the many common head and neck oncological and reconstructive procedures such as thyroidectomy, neck dissection, and oral cavity and scalp reconstruction. His combined expertise in cancer ablation and facial cosmetic and reconstructive surgery enables him to optimize cancer treatment while achieving excellent cosmetic and functional results for his patients. Dr. Singh values the doctor-patient relationship, treating every patient as he would a family member. He has developed evidence-based strategies to enhance this relationship, emphasizing effective communication and care among all team members. By prioritizing holistic care and collaborative approaches, Dr. Singh aims to ensure that each patient feels valued and supported throughout their treatment journey. Dr. Singh is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Tissue Biopsy, and Thyroidectomy. Dr. Singh is board certified in American Board Of Otolaryngology.

Dr. Wilken is a board-certified dermatologist and fellowship trained Mohs micrographic surgeon, and practices medical, surgical and cosmetic dermatology at the Northwell Dermatology offices in Lake Success and Great River.Dr. Wilken graduated from the University of California, Los Angeles with Departmental Honors in Biochemistry, and earned her medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio.Dr. Wilken completed three years of training in Otolaryngology-Head & Neck Surgery at Duke University Medical Center in Durham, North Carolina before deciding to pursue training in Dermatology. She completed a two-year postdoctoral clinical fellowship in the Department of Dermatology at the University of California, Davis with a focus in complex medical dermatology during which time she was involved in multiple clinical trials and investigator-initiated studies spanning a variety of dermatologic conditions including psoriasis, melanoma, autoimmune blistering disorders and atopic dermatitis.Dr. Wilken completed her Dermatology residency training at the University of California, Davis and then went on to complete further fellowship training in Mohs Micrographic Surgery & Dermatologic Oncology at NYU Langone Medical Center.Dr. Wilken s primary clinical focus is in Mohs surgery/cutaneous oncology and the surgical management of skin cancers including basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and melanoma. In addition, Dr. Wilken practices a full range of procedural dermatology services including surgical management of benign skin lesions and cosmetic dermatology services. Dr. Wilken is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, Pyoderma Gangrenosum, and Epidermoid Cyst. Dr. Wilken is board certified in American Board Of Dermatology.

Dr. Sharon is an Associate Professor in the Department of Dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra / Northwell. She is board-certified in Dermatology by the American Board of Dermatology, and she is an ACGME fellowship-trained Mohs Surgeon. Dr. Sharon is the Director of Dermatologic Surgery and Dermato-Oncology at Northwell Health.Dr. Sharon graduated Summa Cum Laude from Columbia University. She earned her medical degree from Weill Cornell Medical College. Dr. Sharon completed her internship at Brigham and Women's Hospital at Harvard Medical School and her dermatology residency at the University of California, Davis. She pursued additional specialized training in cutaneous oncology and laser therapy by completing a fellowship in Mohs Surgery and Cosmetic Dermatology at Oregon Health and Science University. Dr. Sharon also has a special interest in international volunteerism and global health, and she obtained a Diploma in Tropical Medicine at the Gorgas Memorial Institute in Peru.Dr. Sharon s primary area of focus is in diagnosis and management, including Mohs surgery, of skin cancer- melanoma, squamous cell carcinoma, basal cell carcinoma, and rare tumors. Dr. Sharon is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Erythema Multiforme, and Stevens-Johnson Syndrome. Dr. Sharon is board certified in American Board Of Dermatology.

Richard Carvajal is an Oncologist practicing medicine in Lake Success, New York. Dr. Carvajal is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy. Dr. Carvajal is board certified in American Board Of Internal Medicine/Medical Oncology.

Assistant Professor of Radiation MedicineThe Center for Head & Neck OncologyNorthShore-LIJ-Stereotactic-Radiation-CenterHofstra North Shore- LIJ School of Medicine. Dr. Ghaly is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Adenoid Cystic Carcinoma, Olfactory Neuroblastoma, and Teratocarcinosarcoma.

Christopher Barker is a Radiation Oncologist practicing medicine in New York, New York. Dr. Barker is rated as an Elite provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Melanoma of the Eye, and Liver Embolization. Dr. Barker is currently accepting new patients.

Dev Kamdar is an Otolaryngologist practicing medicine in New Hyde Park, New York. Dr. Kamdar is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Mikulicz Disease, Gastrostomy, and Laryngectomy. Dr. Kamdar is board certified in American Board Of Otolaryngology.

My career began at Beth Israel Medical Center/Continuum Health Partners in Manhattan, as a Physician-Scientist at that institution s newly established Institute for Head and Neck and Thyroid Cancer. I developed a basic science research laboratory, collaborating with senior investigators at the NYU School of Dental Medicine. My research was funded through a combination of national society and private foundation career development awards, and resulted in several publications, nationally recognized basic science research in head and neck oncology, and several national presentations and awards. In 2007, I was hired as Chief of the Division of Head and Neck Surgery at Long Island Jewish Medical Center (LIJ), in the early years of the (then) North Shore-LIJ Health System and North Shore-LIJ Cancer Institute. In this role I helped to establish one of the first fully integrated multidisciplinary oncology programs in our growing health system dedicated to the initial evaluation, care and survivorship of cancer patients, specifically those with head and neck tumors. The Head and Neck Oncology Program at Northwell has now evolved into one of regional as well as national renown, with the ability to deliver sophisticated multidisciplinary surgical and nonsurgical head and neck oncologic care at multiple sites throughout our network. Our clinical team also maintains a close collaboration with leading senior basic science investigators at Northwell's Feinstein Institute, focusing on HPV-associated oropharynx cancer. In 2014, I was appointed Northwell Health Cancer Institute s first Director of Surgical Oncology, and served in this position until early 2019. In the Spring of 2019, I was appointed Director of Operations of the Northwell Health Cancer Institute. In this capacity I serve as the liaison between the Institute, its members, and the various hospitals and outpatient cancer treatment facilities throughout the Northwell network where cancer care is delivered. In 2015, I was appointed Chair of LIJ s Commission on Cancer (CoC) recognized Cancer Committee. In this role I have worked with clinical and administrative colleagues to better integrate the inpatient cancer activities and resources of LIJ and North Shore University Hospital with those of our outpatient Cancer Institute facilities. I am presently involved in defining and solidifying Cancer Institute oversight over inpatient cancer related resources and activities, as well as CoC standards. My clinical leadership and program building accomplishments have been recognized both regionally as well as nationally with an American Cancer Society Doctor of Distinction Award (2017), an American Head and Neck Society Presidential Citation (2017), and a position on the Advanced Training Council of the American Head and Neck Society. Dr. Frank is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy. Dr. Frank is board certified in American Board Of Otolaryngology.

Lucio Pereira is an Otolaryngologist practicing medicine in New Hyde Park, New York. Dr. Pereira is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Mikulicz Disease, Tongue Cancer, Gastrostomy, and Laryngectomy. Dr. Pereira is board certified in American Board Of Otolaryngology.

Dr. Sarah Kidwai is a Facial Plastic & Reconstructive Surgeon. She is double board certified in Otolaryngology-Head and Neck Surgery and Facial Plastic & Reconstructive Surgery. Dr. Kidwai has interests in rhinoplasty, facial reconstructive surgery, facial nerve reanimation, facial rejuvenation procedures, as well as facial feminization surgery. Dr. Kidwai is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. Her clinical expertise encompasses Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Recurrent Peripheral Facial Palsy, Facial Paralysis, Parathyroidectomy, and Endoscopy. Dr. Kidwai is board certified in American Board Of Otolaryngology.

Radha Mikkilineni is a Dermatologist practicing medicine in Garden City, New York. Dr. Mikkilineni is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Seborrheic Keratosis, Warts, Squamous Cell Skin Carcinoma, and Basal Cell Skin Cancer.

Dr. Hongbei Wang is an Assistant Professor in Dermatology and in Anatomic Pathology at the Donald and Barbara Zucker School of Medicine at Hofstra / Northwell. She is board certified in Anatomic Pathology, Clinical Pathology and Dermatopathology by the American Boards of Pathology and Dermatology.Dr. Wang received her medical degree and Master of Science from the Second Military Medical University in Shanghai, China. She earned her Ph.D. in Biomedical Sciences from the Worcester Polytechnic Institute and University of Massachusetts Medical School. She completed her residency in Anatomic and Clinical Pathology at the State University of New York Downstate Medical Center, where she was selected as Chief Resident. Dr. Wang then completed her fellowship in dermatopathology at the Ackerman Academy of Dermatopathology.Dr. Wang has significant work experience in both private and academic sectors in dermatolopathology. She has been actively teaching residents in Dermatology and Pathology. Dr. Wang has also published in peer-reviewed literature. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Warts, Eccrine Porocarcinoma, Carney Complex, and Solitary Fibrous Tumor. Dr. Wang is board certified in American Board Of Pathology/Anatomic & Clinical and American Board Of Pathology/Dermatopathology.

Alina G. Bridges, DO is the Director of Dermatopathology & Associate Professor in the Department of Dermatology and Anatomic Pathology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Previously, she served as Director of Immunodermatology at Dermpath Diagnostics in Cincinnati, OH & Emeritus Director of Dermatopathology Fellowship at the Mayo Clinic. Dr. Bridges has been making leadership, advocacy, & health care policy contributions as an advisor for the AMA-RUC, and as a member of the MACRA Hospital Medicine Clinical Subcommittee for the CMS. She is deputy chair of the AAD Dermatopathology Rapid Response & Mohs Committees; a member of the Health Finance Committee, Curriculum Task Force, Appropriate Use, & RBRVS /CPT Committees. She serves on the Health Policy & Work Value Policy, History, Maintenance of Certification, & Program Committee for the American Society of Dermatopathology. She is a member of the American Dermatological Association, mentorship committee for the Women s Dermatologic Society & Scientific Chair for the Noah Worcester Dermatological Society. Dr. Bridges is a nationally & internationally recognized lecturer & researcher, serving as an investigator in digital pathology, AI, bullous disorders, melanoma, pigmented lesions, psoriasis, squamous cell carcinoma, COVID & dendritic cells. She is a frequent, skilled speaker & session chair at national & international meetings on inflammatory dermatopathology, autoimmune diseases in dermatopathology, vasculitis/vasculopathy, hospital dermatology, panniculitis, infectious dermatopathology, pigmented lesions, clinicopathologic cases, drug reactions, & ulcers. Dr. Bridges is extremely dedicated to education, having mentored >100 residents, fellows, & visiting clinicians, with many of her mentees going on to outstanding careers of accomplishment, with academic appointments at Mayo Clinic, Saint Louis University, University of South Florida, Henry Ford Medical Center, University of Utah, University of Texas, University of Chicago, Scripps Clinic, University of California-Los Angeles, London, England, Harvard Medical Center, the United Arab Emirates & Turkey. Dr. Bridges has over 100 publications in well-respected journals such as the JAAD, Nature Immunology, Human Pathology, Mayo Clinic Proceedings, Journal of Cutaneous Pathology, Cardiovascular Pathology, and International Journal of Dermatology, as well as numerous book chapters, letters, and commentaries. She is on the editorial board of the JAAD. Dr. Bridges is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Bullous Pemphigoid, and Squamous Cell Skin Carcinoma. Dr. Bridges is board certified in American Board Of Dermatology and American Board Of Pathology/Dermatopathology.

"Andrew Salama, DDS, MD, is the chief of oral and maxillofacial surgery at Long Island Jewish Medical Center at Northwell. He specializes in head and neck cancer and microvascular reconstruction.Dr. Salama's path toward his specialty actually began in the waiting room of his oral and maxillofacial surgeon, when he was preparing to get his wisdom teeth removed as a college student. Amid the usual magazines were medical journals describing surgeries related to oral and maxillofacial surgery.""I thought it was fascinating, and that led to dental school,"" he recalls. ""On my very first day there, one of the oral and maxillofacial faculty presented a lecture on head and neck cancer, and I remember thinking, 'I want to do that.' It seemed like a dynamic specialty with evidence-based practice, and also one that offered the opportunity to build strong and longitudinal doctor-patient relationships.""After graduating from the University of Maryland Dental School in 1999, Dr. Salama attended the University of Maryland School of Medicine, graduating in 2002. He did his residency in oral and maxillofacial surgery and then completed a two-year fellowship in head and neck oncologic surgery. He remained on faculty for four years before moving to Boston as the director of maxillofacial oncology at Boston University Medical Center. After 11 years in Boston, he joined Northwell in July 2021 with the aim of blending his leadership skills with patient care.""Surgeons only spend about 15 to 20% of their time actually performing surgery, which means it's crucial to find activity that makes the other 80% of time meaningful,"" Dr. Salama explains. ""People simply like working at Northwell; it's a happy place that provides high-quality health care. I came here because it's a supportive environment that is dedicated to positive patient outcomes.""Although Dr. Salama enjoys keeping up with the innovations in his field and drawing on the collaborative environment within Northwell, what he appreciates most in his role are the connections he makes with patients.""There's magic there, when you're working together toward better health,"" he says. ""The relationship and trust between doctors and patients is a large part of what meaningful health care is about. Interacting with patients and their families, and finding solutions to their problems, is what makes me excited to come in every day.""". Dr. Salama is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Ewing Sarcoma, Oral Squamous Cell Carcinoma, Osteotomy, and Glossectomy. Dr. Salama is board certified in American Board Of Oral & Maxillofacial Surgery.

Dr. Laurent Ganry provides surgical answers to facial deformities from diverse origins, restoring dignity for his patients and obtaining esthetic and functional results, while using a patient-centered approach.Dr. Ganry's pursuit of excellence led him to undertake dual fellowships training in Head & Neck OMFS & ENT surgery, combined with a plastic surgery fellowship in Tokyo, Japan, broadening his perspective and skills. He has received multiple awards in surgical innovations and international reconstructive microsurgery competitions, developed a patented medical device in the USA, and published over 30 scientific articles and book chapters.With two decades of experience, Dr. Ganry has honed his skills and knowledge as an attending surgeon in prestigious institutions, such as the Plastic & Reconstructive Surgery Department of Henri Mondor Academic Hospital and the ENT / Head and Neck Surgery Department of Gustave Roussy Cancer Center in France. Dr. Ganry is rated as undefined provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His clinical expertise encompasses Basal Cell Skin Cancer, Tongue Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Bone Graft, and Osteotomy.

Miriam A. Knoll, MD, joined Northwell Health in 2024 as a radiation oncologist. She is also a clinical assistant professor of medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.After attending NYU Grossman School of Medicine, she completed a residency at the Icahn School of Medicine at Mount Sinai, before working at the John Theurer Cancer Center at Hackensack University Medical Center and Montefiore Nyack Hospital. She chose cancer care as a specialty in large part because she saw how collaborative that process needs to be for strong patient outcomes.I love working with a radiation oncology team, because that's truly what each patient needs, she says. Each of us contributes expertise and a different perspective, and that adds up to well-rounded care for each patient.At Northwell, Dr. Knoll's main focus is providing palliative radiation treatment. She communicates to patients how effective treatment can be for treating pain, and with far fewer side effects than many might expect. This type of therapy can really make a difference in helping people feel better, no matter where they are in their cancer journey.In addition to direct care, Dr. Knoll has worked to advance the field and to broaden patient knowledge and access by co-founding and serving at CEO of the Jewish Orthodox Women's Medical Association (JOWMA), as well as publishing articles in both academic journals and consumer publications such as JAMA Oncology, IJROBP, Advances in Radiation Oncology, Huffington Post and Forbes. She is an international speaker and writer focusing on medical care, the physician workforce, women in medicine, and social media in medicine. Dr. Knoll serves on national cancer committees at American Society of Clinical Oncology, American Society for Radiation Oncology, NRG Oncology, and the RTOG Foundation. She serves as a section editor for the journal Advances in Radiation Oncology.Over the course of her career, Dr. Knoll has learned from patients how valuable it is for those going through cancer to have a robust support system around them. That means family and friends and other patients, as well as a cancer care medical team.Ultimately, there are aspects of cancer that we can't control, although we step in and do as much as we can, she says. What we can control is offering as much support as possible so patients can draw on their own resilience for treatment. I see my role as being there for each patient on a personal level, while helping advance research and oncology care in a broader way. Dr. Knoll is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Posterior Fossa Tumor. Dr. Knoll is board certified in American Board Of Radiology/Radiation Oncology.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Seetharamu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.